OCDX News and Press, Ortho Clinical Diagnostics plc From 05/05/21

RARITAN, N.J., May 05, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in-vitro diagnostics (IVD) companies, today announced financial results for the first quarter ended April 4, 2021. Highlights Firs...

Ortho Clinical Diagnostics Launches Quantitative COVID-19 IgG Antibody Test with CE Mark PR Newswire - Ortho's VITROS ® Anti-SARS-CoV-2 IgG Quantitative Antibody test is traceable to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which is d...

Global Transfusion Medicine Leader Ortho Clinical Diagnostics Launches Next Gen ORTHO VISION® Swift Platform PR Newswire ORTHO VISION is the leading choice for blood banks RARITAN, N.J. , May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics ...

Ortho Clinical Diagnostics Recognized With Prestigious Edison Award for Highly Accurate COVID-19 Solutions Capable of Mass-Scale Testing Silver Award Recognizes Antibody and Antigen Tests Canada NewsWire RARITAN, N.J. , April 26, 2021 /CNW/ -- Ortho Clinica...

RARITAN, N.J., April 21, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it will report results for its first quarter 2021 ended April 4, 2021, after the market close on May 5, 20...

Ortho Clinical Diagnostics (OCDX) has received CE Marking for its VITROS SARS-CoV-2 Antigen Test, initially launched in October 2020.The CE Mark allows for more convenient sample collection and expanded viral transport media ((VTM)).Laboratories will now be able to utilize three additional VT...

Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing Receives CE Mark; Allows for More Convenient Sample Collection and Expanded Viral Transport Media Canada NewsWire RARITAN, N.J. , April 13, 2021 /CNW/ -- Ortho Clinical Diagnostics ...

Ortho Announces Plans to Accelerate COVID-19 Antigen and Antibody Test Development Through New Contract with BARDA and the Department of Defense Canada NewsWire - The new contract will deliver Ortho with funding for capacity expansion to provide up to 6.7 million COVID...

Department of Defense (“DOD”) has awarded a $53.7M contract to Ortho Clinical Diagnostics ([[OCDX]] +2.2%) for COVID-19 tests.The agreement made in coordination with the Department of Health and Human Services (“HHS”) relates to COVID-19 antigen and antib...

Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data PR Newswire RARITAN, N.J. , March 23, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one ...